FMR reports disposal of $6.7 million in Avalyn Pharma common shares
AVLN•FMR, a 10% owner of Avalyn Pharma, sold 228,454 common shares on Nov. 9-10, 2026, for about $6.7 million. Its indirect holdings through F-Prime Capital Partners Healthcare Fund V fell to 2,056,081 shares.
1. Share sales
FMR sold 228,454 Avalyn Pharma common shares on Nov. 9-10, 2026. The Nov. 9 sales were 173,661 shares at $29.06 each and 1,339 at $29.75; the Nov. 10 sales were 5,565 at $29.56 and 47,889 at $30.28. A Form 4 dated Nov. 12 reported that indirect holdings through F-Prime Capital Partners Healthcare Fund V fell to 2,056,081 shares.
